We therefore argue that knowledge and understanding of the differences between the molecular modes of action of Sox8 and Sox10 will help to lay out their respective roles not only in developmental myelination and oligodendrocyte physiology, but also in demyelinating diseases and during remyelination. The gene discussed is SOX10; the disease is demyelinating disease.